期刊文献+

探头频率和声波能量对心肌背向散射积分测值的影响 被引量:1

Influences of transducer frequency and acoustic power on the measurements of ultrasonic integrated backscatter
原文传递
导出
摘要 目的 观察超声背向散射积分心动周期变化幅度 (CVIB)测值与探头频率及发射声波能量 (AP)的关系。方法 用HP 5 5 0 0型超声诊断仪 ,取胸骨旁乳头肌短轴观 ,测量了 3 2例正常人在不同探头频率和AP设置条件下 ,左室后壁心肌组织的CVIB值。结果 探头频率为 2 .0MHz时 ,所测CVIB值较探头频率为 3 .0MHz和 4.0MHz时降低。AP过高 ( >3 5dB)或过低 ( <2 0dB)均使CVIB测值明显降低。结论 CVIB测值受探头频率和AP设置的影响 ,测量局部心肌组织的实际最大CVIB值需要选择恰当的探头频率和合理的AP设置。 Objective To investigate the influences of transducer frequency and acoustic power (AP) on the measurements of the magnitude of cyclic variation of integrated backscatter (CVIB).Methods On the left ventricular short axis view at papillary muscle level,the CVIB of posterior wall were measured with different transducer frequency and AP by HP 5500 ultrasonic instrument in 32 healthy volunteers.Results The values of CVIB measured by 2.0 MHz transducer were lower than those by 3.0 MHz and 4.0 MHz transducer (P< 0.01 ,respectively).Lower AP(<20 dB),or excessive settings of AP(>35 dB) induced a minimal CVIB.Conclusions The measurement of CVIB was influenced by the transducer frequency and AP,which have to be selected to measure the largest and more consistent actual CVIB of regional myocardium.
出处 《中华超声影像学杂志》 CSCD 2000年第5期274-275,共2页 Chinese Journal of Ultrasonography
关键词 探头频率 声波能量 CVIB Transducer frequency Acoustic Power Cyclic variation of integrated backacatter
  • 相关文献

参考文献1

  • 1Lang Chunlin,Ultrasoundin Med Biol,1998年,24卷,187页 被引量:1

同被引文献9

  • 1Maceira AM,Barba J,Varo N,et al.Ultrasonic backscatter and serum marker of cardiac fibrosis in hypertensives.Hypertension,2002,39:923-928. 被引量:1
  • 2Lin Y,Shiau R,Yen L,et al.The relation between myocardial cyclic variation of integrated backscatter and serum concentrations of procollagen propeptides in hypertensive patients.Ultrasound Med Biol,2004,30:885-891. 被引量:1
  • 3Lopez B,Gonzalez A,Querejeta R,et al.The use of collagenderived serum peptides for the clinical assessment of hypertensive heart disease.J Hypertens,2005,23:1445-1451. 被引量:1
  • 4Sato A,Takane H,Saruta T.High serum level of procollagen type Ⅲ amino-terminal peptide contributes to the efficacy of spironolactone and angiotensin-converting enzyme inhibitor therapy on left ventricular hypertrophy in essential hypertensive patients.Hypertens Res,2001,24:99-104. 被引量:1
  • 5Devereux RB,Pickering TG,Alderman MH,et al.Left ventricular hypertrophy in hypertension prevalence and relationship to pathophysiology.Hypertension,1987,9:53-58. 被引量:1
  • 6Querejeta R,Varo N,Lopez B,et al.Serum carboxy-terminal propeptide of procollagen type Ⅰ is a marker of myocardial fibrosis in hypertensive heart disease.Circulation,2000,101:1729-1735. 被引量:1
  • 7Lopez B,Querejeta R,Varo N,et al.Usefulness of serum carboxy-terminal propeptide of procollagen type Ⅰ in assessment of the cardioreparative ability of antihypertensive treatment in hypertensive patients.Circulation,2001,104:286-291. 被引量:1
  • 8叶飞,段宝祥,张贞胜,张丰富,耿其吉.扩张型心肌病患者心肌纤维化指标的观察[J].上海医学检验杂志,2002,17(2):77-78. 被引量:5
  • 9蔡恒,张运,张梅,张薇,方永奇,王燕,王荣,葛志明.声学密度技术评价高龄高血压大鼠心肌间质纤维化[J].中华超声影像学杂志,2004,13(2):133-135. 被引量:6

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部